Vein Associates Appoints Holtz Rubenstein Auditors

Vein Associates of America, Inc. (PINKSHEETS: VNAA), a national operator of advanced medical facilities exclusively treating vein disease, announced today that Holtz Rubenstein Reminick LLP ("Holtz") has been appointed as the company's auditors.

"As the Company continues to grow, we needed the expertise of a firm that could support our SEC filing requirements, tax and any other services we may need. Holtz brings us those professional services in addition to specific knowledge and resources via their healthcare consulting group. Holtz will provide their expertise to help us reach our goal by becoming a fully reporting company," said Eric Luetkemeyer, CEO and President.

"Holtz adds the professional and personal touch our Company needs as our success continues. I've known of the firm for many years and their reputation in the financial community and look forward to finally having the opportunity to work with them," said Andrew Schenker, Chief Financial Officer.

About Vein Associates of America, Inc.

Vein Associates of America, Inc. operates advanced specialty medical facilities exclusively treating vein disease using established and the newest treatment techniques available. Nationally the company has several facilities in Florida as well as Alabama, Minnesota, New Jersey, South Carolina and Texas. For more information or location addresses visit www.noveins.com or call 407-708-5818.

About Holtz Rubenstein Reminick LLP.

Holtz Rubenstein Reminick LLP is the "Fastest Growing Accounting Firm in America" (as recognized by both PAR, Sept. 2005, and Accounting Today, Apr. 2006) and one of the Top 25 Accounting Firms in New York (Crain's, Sept. 2005). It is a progressive regional accounting firm, providing a wide variety of accounting, tax and business advisory services to clients throughout the New York metropolitan area. Through its affiliation with DFK International, it also provides services to clients throughout the United States, Canada, Europe, Asia, Mexico and other parts of the world.

Safe Harbor Statement:

Forward-looking statements in this release with respect to Vein Associates Of America, Inc. business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond Vein Associates Of America's control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in Vein Associates Of America's filings with the Securities and Exchange Commission.